KennethCarekinKalunianMD
Rheumatology • San Diego, CARheumatoid Arthritis & Related
Professor, Medicine, UCSD School of Medicine
Dr. Kalunian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 800-926-8273Fax+1 888-539-8781
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1983 - 1985
Olive View/UCLA Medical CenterResidency, Internal Medicine, 1979 - 1983
Saint Louis University School of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1980 - 2026- American Board of Internal Medicine Internal Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) Start of enrollment: 2005 Sep 01
- Using Ultrasonography to Predict Clinical Response to Intraarticular Corticosteroids in Knee Osteoarthritis Start of enrollment: 2005 Dec 01
- Using Ultrasound to Predict Response to Intraarticular Corticosteroids in Knee Osteoarthritis Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, doub...Anca D Askanase, David D'Cruz, Kenneth Kalunian, Joan T Merrill, Sandra V Navarra
The Lancet. Rheumatology. 2024-11-22 - Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV an...Maria Dall'Era, Kenneth Kalunian, Neil Solomons, Matt Truman, Lucy S Hodge
Lupus Science & Medicine. 2024-11-09 - 1 citationsRemission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception co...Megan R W Barber, Manuel Francisco Ugarte-Gil, John G Hanly, Murray B Urowitz, Yvan St-Pierre
Annals of the Rheumatic Diseases. 2024-09-30
Journal Articles
- Psychosis in Systemic Lupus ErythematosusAnca Askanase, Kenneth C Kalunian, M A Dooley, Meggan Mackay, Ellen M Ginzler, Daniel J Wallace, Susan Manzi, Cynthia Aranow, Joan T Merrill, Michelle Petri, Diane L K..., Arthritis & Rheumatology
Other
- Clinical manifestations of osteoarthritisKalunian KC
http://www.uptodate.com/contents/clinical-manifestations-of-osteoarthritis
UpToDate, Wolters Kluwer Health - 2012-12-06 - Diagnosis and classification of osteoarthritisKalunian KC
http://www.uptodate.com/contents/diagnosis-and-classification-of-osteoarthritis
UpToDate, Wolters Kluwer Health - 2012-04-17 - Investigational approaches to the pharmacologic therapy of osteoarthritisKalunian KC
http://www.uptodate.com/contents/investigational-approaches-to-the-pharmacologic-therapy-of-osteoart
UpToDate, Wolters Kluwer Health - 2012-10-12 - Join now to see all
Authored Content
- Novel Serum and Urinary Biomarkers for Use in Diagnosis and Disease Course Management in Lupus NephritisNovember 2022
Press Mentions
Two Promising Treatment Options for SLENovember 16th, 2022
Baricitinib Helps Lupus Patients with Arthritis or Rash – Phase 2 StudyJuly 24th, 2018
Learn About LupusDecember 2nd, 2017- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
